Search

everythinglearnresearchcommunity

for

Search:↓

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.